CHRYSALIX EVC FUND: CELP II
PORTFOLIO MANAGER: RICHARD MACKELLAR
LOCATION: ST. LOUIS, MISSOURI
The need for less expensive and less electricity-intensive carbon capture and sequestration (CCS) technologies.
A patented enzyme immobilization and stabilization polymer technology that potentially cuts the cost of CCS by more than half and puts the resulting captured carbon to work in a variety of potential uses.
The intersection of biology with energy markets is showing great promise. The ability to encapsulate an enzyme and allow it to retain its function outside of its host is a unique and valuable capability. We see the Akermin technology enabling economic large scale separation and capture of CO2 for sequestration.
The scientific team is highly entrepreneurial and innovative and continues to enable the cross-over of biological science into new functional areas. Their IP position is strong and they have developed key industry relationships over the past few years.
Global warming is the defining issue of our times. The ability to capture CO2 from a coal power plant flue gas stream at a very low cost will be fundamental to the continuance of our current lifestyles.